New conjugated urinary metabolites in intermediate type maple syrup urine disease
- Clin Chim Acta. 1987 Oct 30;169(1):77-83. doi: 10.1016/0009-8981(87)90395-0.
Affiliations
- 1. Department of Clinical Chemistry and Blood Coagulation, Karolinska Hospital, Stockholm, Sweden.
PMID: 3677437
DOI: 10.1016/0009-8981(87)90395-0
Abstract
N-Lactylvaline, N-lactylleucine, N-lactylisoleucine and the N-2-hydroxyisovaleryl conjugates of glycine, valine, leucine and isoleucine have been identified in urine from a patient with the intermediate type of maple syrup urine disease.
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Endogenous MetaboliteResearch Areas: Metabolic Disease
-
target: Endogenous Metabolite